Odense C

• The SABLe study Recruiting
  2024-512276-35-00 4 2021-08-09 Multiple Myeloma
• Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease Recruiting
  2023-506853-39-00 6 2021-05-20 Adynamic bone disorder
• Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting
  2023-505483-11-00 6 2021-05-02 Brain abscess
• The DENOCHARCOT trial. Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes. A multicenter, double-blind, … Recruiting
  2024-515365-34-00 6 2020-11-01 diabetic acute Charcot foot (Charcot neuroarthropathy)
• ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling Recruiting
  2023-510527-29-00 4 2020-09-01 Cancer
• An exploratory, randomized, double-blind, multicenter, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and ef … Recruiting
  2024-518384-36-00 4 2020-08-31 Idiopathic membranous nephropathy and severe proteinuria
• Goal directed fluid removal in critically ill patients with fluid overload Recruiting
  2024-512186-14-00 6 2020-08-24 Fluid overload/fluid accumulation
• A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyel … Recruiting
  2023-507885-21-00 4 2020-08-18 Chronic Inflammatory Demyelinating Polyneuropathy
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
• A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting
  2022-501050-11-01 10 2020-07-13 Acute Lymphoblastic Leukaemia
• International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica … Recruiting
  2022-501454-11-00 5 2020-02-05 standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
• SIOP RANDOMET 2017 Recruiting
  2023-508926-91-00 5 2019-12-05 Stage IV childhood renal tumour with pulmonary +/- non-pulmonary metas
• Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting
  2024-517854-91-00 5 2019-08-05 Metastatic or high-risk recurrent prostate cancer managed with androge
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 5 2019-08-01 Lymphoblastic lymphoma
• The RIME-IVF study - Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricul … Recruiting
  2024-518057-41-00 6 2019-02-22 Unexplained cardiac arrest patients after thorough investigations (Idi
• Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting
  2023-504201-36-00 10 2018-12-21 Defined by parent protocol. The study will enroll all adult and paedia
• Extension Study for Participants in Studies That Include Pembrolizumab Recruiting
  2022-501254-10-00 5 2018-08-24 Advanced tumors
• Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids. The MEMBRAINS trial Recruiting
  2024-516585-11-00 4 2018-06-12 Advanced melanoma
• SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym … Recruiting
  2024-512222-28-00 10 2015-06-02 Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
• Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting
  2023-506027-29-00 5 2014-10-01 Children, adolescents and adults with newly diagnosed diffuse intrinsi
• MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting
  2024-515626-92-00 4 2013-10-18 recurrent/progressive medulloblastoma, ependymoma and atypical teratoi
• A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine … Ended recruitment
  2023-505829-14-00 5 2026-06-02 First recurrence glioblastoma
• A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou … Ended recruitment
  2025-522598-12-00 10 2025-12-17 Untreated Metastatic Pancreatic Ductal Adenocarcinoma
• A study of S095035 as a single agent and in combination in adult participants with advanced or metastatic solid tumors with deletion of MTAP Ended recruitment
  2025-521249-25-00 7 2025-10-30 MTAP-deleted advanced or metastatic solid tumors

Showing 241–264 of 467 trials